Product Information
LEVOTHYROXINE 137 MCG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.0630 per EA under NDC 00480871098. Its NADAC has been published 192 times since Oct 26, 2022.
Strength
137 ug/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00480871098
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LEVOTHYROXINE SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA207588On Market Since
9/21/2022
Pharmacological Classes
Price Statistics
The NADAC for LEVOTHYROXINE 137 MCG TABLET has been published 192 times since Oct 26, 2022, and over the history we have for it it has declined 63.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0630 per EA |
|---|---|
| All-time high | $0.1733 (Nov 16, 2022) |
| All-time low | $0.0555 (Jul 17, 2024) |
| 52-week high | $0.0767 |
| 52-week low | $0.0630 |
| Median price | $0.0820 |
| Average price | $0.0912 |
| Largest weekly change | +51.0% (Jun 19, 2024) |
| Weeks tracked | 192 |
| Tracking since | Oct 26, 2022 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LEVOTHYROXINE 137 MCG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LEVOTHYROXINE 137 MCG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.0630 per EA (NDC 00480871098), effective Jun 24, 2026.
How has the price of LEVOTHYROXINE 137 MCG TABLET changed over time?
Over the history we have for it, the NADAC for LEVOTHYROXINE 137 MCG TABLET has declined 63.7%. It has been tracked across 192 weekly CMS publications since Oct 26, 2022.
What are the highest and lowest recorded NADAC prices for LEVOTHYROXINE 137 MCG TABLET?
Since Oct 26, 2022, the NADAC for LEVOTHYROXINE 137 MCG TABLET has ranged from a low of $0.0555 (Jul 17, 2024) to a high of $0.1733 (Nov 16, 2022), with a median of $0.0820 per EA.
Are there cheaper alternatives to LEVOTHYROXINE 137 MCG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as LEVOTHYROXINE 137 MCG TABLET, but none are currently priced below it.
Who manufactures LEVOTHYROXINE 137 MCG TABLET?
LEVOTHYROXINE 137 MCG TABLET (NDC 00480871098) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification